Basics Structure Therapeutics Inc. IPO Date: February 3, 2023 Sector: Healthcare Industry: Biotech Market Cap: $1.61B Activated in VL: True Average Daily Range Avg Daily Range: $1.07 | 3.19% Avg Daily Range (30 D): $0.73 | 2.89% Avg Daily Range (90 D): $0.58 | 2.66% Institutional Daily Volume Avg Daily Volume: .69M Avg Daily Volume (30 D): .9M Avg Daily Volume (90 D): .82M Trade Size Avg Trade Size (Sh.): 86 Avg Trade Size (Sh.) (30 D): 82 Avg Trade Size (Sh.) (90 D): 89 Institutional Trades Total Inst.Trades: 1,795 Avg Inst. Trade: $1.52M Avg Inst. Trade (30 D): $1.58M Avg Inst. Trade (90 D): $1.96M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $1.3M Avg Closing Trade (30 D): $1.76M Avg Closing Trade (90 D): $1.34M Avg Closing Volume: 40.86K     News Sep 12, 2025 @ 12:15 PM This Under-the-Radar Healthcare Stock Could Soar i... Source: Prosper Junior Bakiny Aug 17, 2025 @ 11:15 AM This Healthcare Stock's Bad News Could Create a $1... Source: Prosper Junior Bakiny Jun 20, 2025 @ 11:30 PM Structure Therapeutics Announces Two Late-Breaking... Source: N/A Apr 14, 2025 @ 3:12 PM Why Eli Lilly, Novo Nordisk, and Viking Therapeuti... Source: Rich Smith Jun 17, 2024 @ 1:53 PM Could Structure Therapeutics Become the Next Novo ... Source: newsfeedback@fool.com (Alex Carchidi) Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.05 $-.36 $-.27 Diluted EPS $-1.05 $-.36 $-.27 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -178.95M $ -61.66M $ -46.83M Operating Income / Loss $ -219.66M $ -70.45M $ -56.31M Cost of Revenue $ $ $ Net Cash Flow $ -234.6M $ -5.1M $ -17.39M PE Ratio